Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05576168Completed
Open-label trial (2 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoint: Retinol Binding Protein 4 at 3 years. Started May 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05576168.